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Gsa meets its target — shedding light on a key signal transduction
event
John J Dumas and David G Lambright*
The recently determined crystal structure of Gsa bound to
a catalytically active form of adenylyl cyclase reveals the
location of the enzyme’s active site and provides the first
view of heterotrimeric G protein a subunit activating a
downstream effector. Comparison with the structure of a
catalytically inactive form of adenylyl cyclase suggests a
plausible allosteric mechanism whereby the synergistic
activators Gsa and forskolin stimulate the activity of
adenylyl cyclase.
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The mechanisms by which extracellular signals modulate
levels of intracellular second messengers have been the
subject of intense biochemical investigation since the
discovery of the first known second messenger, cyclic
AMP, in the 1950s [1]. Over the last five years, crystallo-
graphic studies have begun to unravel the structural basis
of G-protein-coupled signaling. The latest crystallographic
milestone represents the culmination of years of detailed
biochemical analyses combined with a clever strategy to
convert the membrane-bound form of adenylyl cyclase
(AC), the enzyme responsible for synthesis of cAMP, into
a soluble enzyme that retained both catalytic activity and
the ability to be modulated by forskolin — a plant ter-
penoid known to directly activate AC — and G proteins.
In the December 12th issue of Science, Tesmer et al. report
the crystal structure of a complex consisting of the soluble
catalytic domains of AC, activated by forskolin and the
GTP-bound a subunit of Gs, the heterotrimeric G protein
(G
abg
) that activates AC [2].
Heptahelical receptors, which are activated by ligand
binding, catalyze the exchange of GTP for GDP on the a
subunits of heterotrimeric G proteins. The conformational
switch induced by GTP binding activates G
a
subunits and
promotes the release of G
bg
. The activity of a variety of
downstream effectors, typically ion channels or enzymes
that generate second messengers, has been shown to be
modulated by G
a
·GTP or the released G
bg
. Perhaps the
most intensively studied G-protein target is AC, the mem-
brane-bound enzyme that converts ATP into the intra-
cellular second messenger cAMP. To date, ten different
isoforms of AC have been identified [3,4]. Although differ-
ences exist with respect to regulation by G
bg
subunits and
the inhibitory G protein, Gia , all ten isoforms are activated
by Gsa and forskolin, and are inhibited by analogues of
adenosine (P-site inhibitors) in the presence of pyrophos-
phate and Mg2+. ACs have two homologous cytoplasmic
domains, designated C1 and C2, which resemble domains
found in guanylyl cyclases. Each of these cytoplasmic
domains can be independently expressed as a soluble
homodimer, capable of binding two molecules of forskolin
but lacking catalytic activity. A key biochemical break-
through was the expression of soluble, catalytically active,
C1–C2 fusion proteins [5]. Gilman and colleagues later
showed that the inactive C1 and C2 homodimers, when
mixed together, spontaneously form C1–C2 heterodimers,
possessing both catalytic activity and the ability to be stim-
ulated by forskolin and GTP-bound Gsa [6,7]. Moreover,
functional heterodimers could also be obtained by mixing
the C1 and C2 domains from different isoforms. Indeed, it
was just one such heterodimer (VC1–IIC2; the Roman
numerals designate the isoform) that was used in the crys-
tallographic studies of Tesmer et al. [2].
Orientation with respect to the membrane
Figure 1 shows the structure of Gs a bound to the C1–C2
heterodimer of AC. The location of the N terminus of Gsa
(reversibly palmitoylated in vivo), as well as the N and C
termini of the C1 and C2 domains, orients the ‘dorsal’ face
of the C1–C2 heterodimer toward the membrane surface
and the membrane spanning segments of adenylyl cyclase.
In this proposed orientation, the cleft between the two
domains on the ‘ventral’ surface of the heterodimer is
roughly parallel to the plane of the membrane, so that the
forskolin-binding site and the active site face the cyto-
plasm. The various membrane-associated modulators of
AC, including Gs a , Gia and Gbg , would then be con-
strained to interact with peripheral regions of the C1–C2
heterodimer remote from the enzyme active site. On the
basis of studies which indicate that Gia and Gsa do not
compete for binding to AC [8], Tesmer et al. propose that
the binding site for Gia might be located opposite that for
Gs a , between the a 3 helix and the a 1–a 2 loop of the C1
domain. The binding of Gs a and Gia to pseudosymmetric
sites may help to explain how Gia selectively inhibits a
subset of AC isoforms, whereas Gsa activates all isoforms
Locating the active site
The overall structure of the C1–C2 heterodimer is similar to
that of the C2 homodimer. The C2 homodimer binds two
molecules of forskolin in a dyad symmetric arrangement,
with the binding sites situated at opposite ends of the
shallow ventral cleft formed at the interface between the
two domains [9]. In contrast, only a single molecule of
forskolin is bound to the pseudosymmetric C1–C2 hetero-
dimer (Figure 2) [2]. Comparison of the forskolin-binding
site with the pseudosymmetric site reveals two key amino
acid differences that explain how a second molecule of
forskolin is excluded from binding to the C1–C2 hetero-
dimer. Asn1025 and Asp440 in the pseudosymmetric site
replace Thr512 and Ser942, respectively, in the forskolin-
binding site. The sidechains of both asparagine and
aspartate would sterically prohibit binding of a second
molecule of forskolin to this site. Although the potential
steric clash with Asn1025 could be alleviated by rotation
of the C1 domain to coincide with the corresponding
domain in the C2 homodimer, the predicted steric clash
with Asp440 would remain.
To locate the binding site for P-site inhibitors, Tesmer et
al. soaked native crystals with a P-site inhibitor consisting
of 2 ¢ ,d3 ¢ -AMP, pyrophosphate and Mg2+. Interestingly,
the P-site inhibitor binds to a site that is pseudosymmet-
ric with the forskolin-binding site and at the opposite end
of the ventral cleft from the Gs a -binding site. Like the
forskolin-binding site, the P-site is formed by structural
elements from both the C1 and C2 domains. The pyro-
phosphate moiety is situated near a strand–loop–helix
element structurally reminiscent of the P-loop common to
nucleotide-binding proteins and interacts with the Mg2+
ion and three basic residues. Mg2+ binds with apparent
octahedral geometry and four of six expected ligands
are visible in the structure, including two aspartic acid
residues (Asp396 and Asp440), a mainchain carbonyl
oxygen (Ile397) and a b -phosphate oxygen of the pyro-
phosphate group. The remaining sites are presumably occu-
pied by water molecules.
Binding studies [10], as well as the structure of the complex
[2], suggest that P-site inhibitors bind to the same site as
the substrate, exerting their inhibitory effect by mimicking
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Figure 1
The complex of Gsa ·GTPg S and the C1–C2 heterodimer of adenylyl
cyclase. The ras-like domain of Gsa is shown in dark grey; the helical
domain in light grey; and the switch II domain (Sw II) in red. Adenylyl
cyclase (AC) fragment VC1 is shown in green and IIC2 in purple.
(a) N termini are presumed to be oriented toward the lipid bilayer, thus
the ‘dorsal surface’ of AC faces the membrane, whereas the ventral
surface faces the cytoplasm. (b) Detailed view showing Sw II of Gs a
(same orientation as above) and the regions of C1–C2 with which it
interacts. (c) The complex of Gsa ·GTPg S and C1–C2 rotated about
the horizontal axis by 70° relative to (a). (d) Detailed view showing the
interface between Gsa and C1–C2, in the same orientation as (c).
(Figure reproduced from [2] with permission.) 
the products of the reaction, cAMP and pyrophosphate.
Because it was not possible to locate the substrate-binding
site by soaking native crystals with the non-hydrolyzable
ATP analogue Ap(CH2)pp, Tesmer et al. constructed a
model for ATP bound in the active site using the location of
the 2¢ ,d3¢ -AMP, pyrophosphate and Mg2+ of the P-site
inhibitor complex to position the corresponding elements of
ATP. The resulting conformation of ATP places the 3¢ OH
group of the ribose moiety in a favorable orientation for in-
line attack of the a -phosphate group (Figures 3a and b).
This model also explains why mutation of Arg1029 reduces
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Figure 2
The binding sites of the P-site inhibitors, forskolin and ATP on the
ventral surface of the C1–C2 heterodimer. 2¢ ,d3¢ -AMP and
pyrophosphate of the P-site inhibitor are bound in the ventral cleft of
C1–C2 at the end furthest from the site of interaction with Gsa .
Forskolin binds to a site that is pseudosymmetric to the P-site. Regions
of the C1–C2 heterodimer which have a different conformation in the
absence of the P-site inhibitor are shown in transparent pink. (Figure
reproduced from [2] with permission.) 
Figure 3
The mechanism of Gsa activation of the C1–C2 heterodimer.
(a) Model of ATP·Mg2+ bound to the catalytic site of VC1–IIC2. The
unactivated heterodimer (based upon structure of the IIC2 homodimer)
is shown in transparent pink and the activated C1–C2 is solid green.
The position of ATP is modeled on the basis of the position of 2¢ ,d3¢ -
AMP and pyrophosphate in the active site. (b) Schematic diagram of
the putative transition state for GTP hydrolysis in which Arg1029
stabilizes the pentavalent phosphate intermediate. (c) Model of the
conformational changes accompanying AC activation by Gs a . Binding
of Gsa results in a 7° rotation of the C1 domain with respect to C2;
color coding as for (a). (Figure reproduced from [2] with permission.)
kcat but has no effect on Km: the guanidylyl group of
Arg1029 is located near the a -phosphate group of ATP and
is predicted to stabilize the transition state in a manner rem-
iniscent of the conserved catalytic arginine in heterotrimeric
G protein a subunits and the ‘arginine finger’ of GTPase-
activating proteins that stabilize the transition state for
GTP hydrolysis [11–14].
The interface between Gsa and adenylyl cyclase
The interaction between Gs a and the C1–C2 domains of
AC buries 1800 Å2 of solvent accessible surface area in a
single contiguous interface. All but a handful of Gsa
residues that contribute to this interaction are located
in either the switch II region (specifically the a 2 helix
and a 2– b 4 turn) or in the adjacent a 3– b 5 loop. Interest-
ingly, contacts between C1–C2 and residues within the
a 4–b 6 loop of Gsa are not observed. Scanning-mutagenesis
experiments, in which residues of Gs a were replaced with
corresponding residues from Gia , indicated that the a 4–b 6
loop of Gs a is important for interaction with AC [15]. One
explanation for this apparent conundrum is that the a 4–b 6
loop interacts with a region of the cytoplasmic face of AC,
which lies outside the C1 and C2 domains. An alternative
and perhaps simpler explanation is that the conformations
of the a 3–b 5 and a 4–b 6 loops are mutually dependent.
Substitutions within the a 4–b 6 loop might therefore alter
the conformation of key residues in the a 3–b 5 loop, which
in turn interact directly with AC. Indeed, as Sunahara et al.
observe, the primary and tertiary structures of these loops
differ substantially between Gia and Gsa [16]. Moreover,
the conformations of these loops in Gs a are stabilized
by hydrogen-bonding and stacking interactions involving
Trp277 and His357 (Figure 4).
Mechanism of adenylyl cyclase activation
How is the binding of Gs a at a relatively small interface
at one end of the C1–C2 dimer communicated to the
active site some 30 Å away? Evidently, a global confor-
mational change is required. The conformational change
induced by Gs a and/or forskolin binding, however, does
not alter significantly the Km of ATP or the Ki for
Ap(CH2)pp, but rather reorients catalytic residues to
accelerate the rate of cAMP formation. To deduce a
plausible model for the nature of the conformational
change leading to cyclase activation, Tesmer et al. compare
the structure of forskolin- and Gs a -activated C1–C2 het-
erodimer with that of the inactive C2 homodimer
(Figure 3c). Gs a appears to activate AC by inserting its
a 2 (switch II) helix into a shallow cleft formed by the a 3 ¢
helix and a 1 ¢ – a 2 ¢ loop of the C2 domain. The a 1 ¢ – a 2 ¢
loop is displaced by 3 Å relative to the a 3 ¢ helix. These
changes are transduced to the C1 domain through an
extensive interface centered on the b 5–a 4 region, leading
to a small but significant global rotation of the C1
domain that repositions key active-site residues.
The road ahead
The most important unresolved question about this signal-
ing pathway — how an activated receptor activates a het-
erotrimeric G protein — also poses some of the greatest
biochemical hurdles: expression, purification, solubilization
and crystallization of an integral membrane receptor.
However, with recent success on two crucial fronts — the
high level expression of the a -factor receptor in yeast [17]
and the atomic resolution structure of bacteriorhodopsin
crystallized from lipidic cubic phases [18] — an atomic level
description of heterotrimeric G protein signaling, from
receptor to effector, seems almost within reach.
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